Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead.
Issue Brief (Commonw Fund)
; 2019: 1-11, 2019 Mar 01.
Article
en En
| MEDLINE
| ID: mdl-30990594
ABSTRACT
Issue Pharmacy benefit managers (PBMs) are responsible for negotiating payment rates for a large share of prescription drugs distributed in the U.S. Recently, policymakers have expressed concern that certain PBMs' business practices may not be consistent with public policy goals to improve the value of pharmaceutical spending. Goal We sought to explain key controversies related to PBM practices and their roles in driving value in the pharmaceutical market. Methods:
Literature review and feedback from top experts on PBM business practices and potential policy solutions. Key Findings andConclusion:
In some cases, PBMs' use of rebates has contributed to high pharmaceutical costs, yet proposed solutions to the rebate controversy--including passing the rebate through to payers or patients--will not on their own reduce overall pharmaceutical spending without other policies that drive toward value. Policymakers seeking to reform pharmaceutical reimbursement beyond the practice of rebates will need to consider these changes in light of the recent mergers between PBMs and insurers and the entry of new market competitors.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Personal Administrativo
/
Beneficios del Seguro
/
Seguro de Servicios Farmacéuticos
Tipo de estudio:
Prognostic_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Issue Brief (Commonw Fund)
Asunto de la revista:
PESQUISA EM SERVICOS DE SAUDE
Año:
2019
Tipo del documento:
Article